• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Disciform Macular Scarring

Article

A sudden, severe decrease in the vision in her left eye brought an 80-year-old woman in for an evaluation. Her best corrected visual acuity was 20/200 in that eye.

A sudden, severe decrease in the vision in her left eye brought an 80-year-old woman in for an evaluation. Her best corrected visual acuity was 20/200 in that eye.

The results of external examination of both eyes were unremarkable. A dilated fundus examination of the left eye found a large but subtle serous elevation in the macular area; there were no hemorrhages or exudates. A fluorescein angiogram confirmed an occult subretinal neovascular membrane that completely encompassed the macular area (A).

This patient was originally evaluated 4 years ago, before any viable therapies were available to treat this form of wet age-related macular degeneration. She was observed periodically, but had no treatment.

The patient's vision in the left eye has stabilized at finger counting at 2 feet. She also has a large fibrotic disciform macular scar (B). This is the natural end point of an untreated macular neovascular membrane; there is no known treatment.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
© 2024 MJH Life Sciences

All rights reserved.